Our Pipeline
Blue Note's products will serve all cancer patients, from early stage through survivorship, in both the in-patient and out-patient settings.
Product Candidate
|
Disease Progression
|
Development
|
Proof of Concept
|
Pivotal Trial
|
FDA Review
|
BNT001
|
Early - Mid Stage
|
✕
|
✕
|
✕
|
|
BNT200
|
Acute In-patient
|
✕
|
✕
|
|
|
BNT300
|
Late Stage
|
✕
|
|
|
|
BNT400
|
Survivorship
|
✕
|
|
|
|
Product Candidate
|
Disease Progression
|
Status
|
BNT001
|
Early - Mid Stage
|
2
|
BNT200
|
Acute In-patient
|
1
|
BNT300
|
Late Stage
|
0
|
BNT400
|
Survivorship
|
0
|
Status:
0 = Development
1 = Proof of Concept
2 = Pivotal Trial
3 = FDA Review